X0306 4 2022-08-12 false 0001831363 Terns Pharmaceuticals, Inc. TERN 0001767584 Lu Hongbo C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 true false false false Common Stock 2022-08-12 4 P false 1123021.00 2.98 A 1480374.00 I See Footnote Common Stock 2022-08-15 4 P false 1218.00 2.99 A 1481592.00 I See Footnote Common Stock 2022-08-16 4 P false 1500000.00 2.42 A 2981592.00 I See Footnote Pre-funded Warrants (right to buy) 0.0001 2022-08-16 4 P false 1500000.00 2.4199 A Common Stock 1500000.00 1500000.00 I See Footnote The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $2.83 to $3.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4. The securities are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As a managing member of Vivo Opportunity, LLC, Hongbo Lu shares voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. with four other managing members but disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein. The price reported herein is a weighted average price. These shares were acquired on the open market in multiple transactions at prices ranging from $2.96 to $3.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (3) to this Form 4. Vivo Opportunity Fund Holdings, L.P. acquired 1,500,000 shares of Common Stock at $2.42 per share and 1,500,000 pre-funded warrants at $2.4199 per warrant in an underwritten offering. The pre-funded warrants have no expiration date and are exercisable immediately, subject to a 4.99% beneficial ownership limit. /s/ Bryan Yoon, as Attorney-in-Fact for Hongbo Lu 2022-08-16